Effect of oral Royal jelly on menopausal symptoms and sexual function

Effect of oral Royal jelly on menopausal symptoms and sexual function in 50-60 years old menopausal women

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT201306022172N14

Enrollment

110

Registered

2013-06-12

Start date

2013-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sexual disfunctions , menopause symptems, Symptoms of Menopause. Other sexual dysfunction, not caused by organic disorder or disease,

Interventions

Control group: Placebo Capsules, 100 Mg capsules once daily in tow month

Intervention 1: Intervention group: Royal Jelly Capsules, 100 Mg capsules once daily in tow month. Intervention 2: Control group: Placebo Capsules, 100 Mg capsules once daily in tow month.

Treatment - Other

Placebo

Intervention group: Royal Jelly Capsules, 100 Mg capsules once daily in tow month.

Eligibility

Sex/Gender

Female

Age

50 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Not having physical and psychological diseases in women and their spouses, having coitus at least twice in a month, Not using of sedative and hypnotic drugs, HRT and herbal medicines more than once a week, Not allergic to honey consumption and BMI less than 28 kg m . Exclusion criteria: Not having sexual activity during the study, not using the drug under investigation for more than 6 days in a month, using of any hormonal and herbal medication, using of Soy more than one meal per week, starting any vegetarian diet and allergic and not using of Antibiotics or Antacids during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Menopausal symptoms score. Timepoint: End of first month of intervention. Method of measurement: Menopause Rating Scale (MRS) questionnaire.;Sexual function score. Timepoint: End of first month of intervention. Method of measurement: sabbastberg sexual function questionnaire.	—

Secondary

Measure	Time frame
Sexual function score. Timepoint: End of first and second month of intervention. Method of measurement: sabbastberg sexual function questionnaire.;Menopausal symptoms score. Timepoint: End of first and second month of intervention. Method of measurement: Menopause Rating Scale (MRS) questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsimin Taavoni

Nursing and Midwifery Faculty, tehran University of Medical Sciences

staavoni14@yahoo.com+98 21 6692 1228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026